Startseite New derivatives of a natural nordentatin
Artikel Open Access

New derivatives of a natural nordentatin

  • Tin Myo Thant , Nanik Siti Aminah EMAIL logo , Alfinda Novi Kristanti , Rico Ramadhan , Hnin Thanda Aung und Yoshiaki Takaya
Veröffentlicht/Copyright: 3. August 2020

Abstract

New derivatives were obtained from natural nordentatin (1) previously isolated from the methanol fraction of Clausena excavata by an acylation method. Herein, we report ten new pyranocoumarin derivatives 1a–1j. Their structures were elucidated based on UV-vis, FT-IR, NMR, and DART-MS data. The α-glucosidase inhibition and anticancer activities of nordentatin (1) and its derivatives were also evaluated. The α-glucosidase inhibition assay exhibited that the derivatives 1b, 1d, 1e, 1f, 1h, 1i, and 1j possess higher inhibitory activity for α-glucosidase with IC50 values of 1.54, 9.05, 4.87, 20.25, 12.34, 5.67, and 2.43 mM, whereas acarbose was used as the positive control, IC50 = 7.57 mM. All derivatives exhibited a weak cytotoxicity against a cervical cancer (HeLa) cell line with the IC50 between 0.25 and 1.25 mM. They also showed moderate to low growth inhibition of a breast cancer (T47D) cell line with IC50 values between 0.043 and 1.5 mM, but their activity was lower than that of the parent compound, nordentatin (1) (IC50 = 0.041 mM).

1 Introduction

Clausena excavata Burm f. belongs to the Rutaceae family and grows mainly in south and southeast Asia [1]. The plant is a wild shrub; its leaves, twigs, and root barks are used as traditional medicine for the treatment of cold, malaria, abdominal pain, snake-bite, viral infections (e.g., HIV), and dermatopathy. The plant is reported to contain bioactive constituents with antibacterial, antifungal, antimycobacterial, antinociceptive, in vivo immunomodulating, and insecticidal properties. Phytochemical studies have revealed that C. excavata is a rich source of coumarins [2,3], carbazole alkaloids [4], and limonoid [5]. Coumarins are plant-derived compounds with a benzopyrone moiety. They possess a wide variety of biological activities. Coumarins and their derivatives are being extensively studied for their biological activities, low toxicity, and low drug resistance properties [6,7].

It has been reported that nordentatin exhibits hypoglycemic activity [8]. The conversion reaction of this compound into its ester derivative is desired, as the derivative is expected to possess more potent biological activities, especially as an antidiabetic medicine in the future. Diabetes mellitus is a chronic disease caused by the dysfunction of carbohydrate metabolism. It has been recognized as one of the most serious public health problems globally. The International Diabetes Federation has estimated that 425 million people worldwide have diabetes. The number will increase to 642 million by 2040 [9,10,11]. Recently, there has been immense interest in the study of enzymes as drug targets. Especially, the inhibition of α-glucosidase can help in controlling postprandial glucose levels in diabetic patients. α-Glucosidases (α-d-glucoside glucohydrolase EC. 3.2.1.20) are membrane-bound enzymes, located in the epithelium of the small intestine, and the key enzymes of carbohydrate digestion. The inhibitors of α-glucosidase can delay the digestion of starch and other dietary sugars, and thus they prevent the onset of hyperglycemia and maintain the normal blood sugar level [9,10,11]. Clinical trials have already shown that α-glucosidase inhibitors can improve long-term glycemic control and decrease hemoglobin A1c (HbA1c) levels in patients with type II diabetes. They can also delay the development of type II diabetes in patients with impaired glucose tolerance [12]. Inhibitors of α-glucosidase such as voglibose, miglitol, and acarbose are currently used clinically, but their use is limited due to their adverse effects, such as diarrhea, abdominal cramping, flatulence, and vomiting. Therefore, much effort has been focused to develop effective α-glucosidase inhibitors from natural sources [13,14,15].

Cancer, in its various forms, is one of the major causes of death of the human population. Among them, cervical and breast cancers are the most common causes of cancer-related deaths in women globally [15,17]. Several natural products of plant origin could potentially be used as cancer chemotherapeutic agents. Some of the currently used plant-derived anticancer agents include podophyllotoxin, taxol, vincristine, and camptothecin [17]. The conversion reaction of marchantin to its ester derivatives increases the anticancer activity [18]. In the present work, we semi-synthesized pyranocoumarin benzoate derivatives from nordentatin (1) by using different benzoyl chlorides. Subsequently, the inhibitory effects of the resulting derivatives and of the parent compound against α-glucosidase enzymes and two cancer cell lines (HeLa and T47D) were evaluated and compared.

2 Materials and methods

2.1 Materials

2.1.1 Materials for synthesis

NMR experiments were performed on Bruker 600 MHz (1H) and 151 MHz (13C) instruments in CDCl3 solvent. MS data were recorded on a DART-MS instrument. Melting points were determined on a Stuart (SMP30) instrument. Infrared spectra were recorded on an IR Tracer-100, ν in cm−1. The UV-vis spectra were obtained on a Shimadzu (UV-1800) UV-vis spectrometer. The target compounds (1a–1j) were semi-synthesized by an acylation method with slight modification [19,20]. The starting material, nordentatin (1), was collected from our previous research [2]. Reagents such as 4-bromobenzoyl chloride, 3-chlorobenzoyl chloride, 2-chloro-4-nitrobenzoyl chloride, 3-chloro-4-fluoro benzoyl chloride, 3-bromo-benzoyl chloride, 4-butylbenzoyl chloride, 2,4,6-trichlorobenzoyl chloride, 3-trifluoromethylbenzoyl chloride, 3,5-bis(trifluoromethyl)benzoyl chloride, and 4-iodobenzoyl chloride (Wako, Japan) were used for the modification of compound 1 (nordentatin). Pyridine and 4-dimethylamino pyridine were used as catalysts. The reaction products were isolated by column chromatography on silica gel 60 (0.063–0.200 mm; Merck, Germany), by eluting with n-hexane and dichloromethane (20–100%). The reaction progress and the purity of the obtained compounds were monitored by p-TLC (preparative thin layer chromatography) on UV-254 plates (n-hex:CH2Cl2, 9:1; detection under UV light and by spraying anis aldehyde, followed by heating). The solvents (CH2Cl2, n-hex, and EtOAc) were purified by standard methods and distilled just before use.

2.1.2 Materials for antidiabetic and cytotoxic testing

The α-glucosidase from Saccharomyces cerevisiae (EC 3.2.1.20), and 4-nitrophenyl α-d-glucopyranoside (p-NPG) were obtained from Sigma-Aldrich. Spectrophotometric measurements for the yeast α-glucosidase inhibition were recorded on an i-Mark microplate reader.

The materials used in the cytotoxicity test with the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium-bromide (MTT) cell viability assay performed on cervical (HeLa) and breast (T47D) cancer cell lines are as follows: Dulbecco’s Modified Eagle’s Medium, fetal bovine serum (FBS) 10% (w/v), dimethyl sulfoxide, phosphate buffer solution, MTT, phenazine methosulfate, sodium dodecyl sulfate 10% (w/v), and HCl 0.1 N.

2.2 Methods

2.2.1 General procedure for the modification of nordentatin (1) with benzoyl chloride derivatives by an acylation method

Esterification of nordentatin (1) was carried out by an acylation method [6,15] (Figure 1). First, around 100 mg of sample (1) was put in each flask. It was dissolved by adding 2 mL of pyridine and 10 mg of 4-(dimethylamino)-pyridine (DMAP) to the mixture. Subsequently, the mixture was stirred on a magnetic stirrer, and different kinds of benzoyl chlorides were added slowly. Then, the reaction was allowed to proceed at room temperature for 1 h. The mixture was checked with TLC at 30 min intervals until the reaction was completed. A volume of 30 mL of EtOAc and 30 mL of distilled water were added to the product mixture. Pyridine was neutralized with 1 M concentrated HCl. The mixture was shaken vigorously three times by using a separating funnel and the organic layer was collected. The aqueous layer was exacted three times with 30 mL of EtOAc. The EtOAc portion was combined and dehydrated with brine water and anhydrous magnesium sulfate. The solvent was removed using a rotary evaporator. Finally, the product mixtures were chromatographed and the pure compounds 1a to 1j were obtained.

Figure 1 Scheme for the semi-synthesis of pyranocoumarin benzoate derivatives.
Figure 1

Scheme for the semi-synthesis of pyranocoumarin benzoate derivatives.

2.2.2 α-Glucosidase inhibition assay

The inhibition activity of all isolated compounds against yeast was determined by the method disclosed by Ramadhan et al. [21] with slight modifications. A sample (10 µL) was mixed with yeast (0.4 U/mL) in 1 mM phosphate buffer (pH 6.9), followed by shaking with a microplate shaker for 2 min and pre-incubation at 37°C for 10 min. The reaction mixture was added to 50 µL of p-nitrophenyl-α-d-glucopyranoside (p-NPG). Subsequently, the mixture was placed in an incubator at 37°C for 20 min. After the incubation, the reaction was quenched by adding Na2CO3 (100 µL). The release of p-nitrophenoxide from p-NPG was detected with a microplate reader at 415 nm (i-Mark ELISA [enzyme-linked immunosorbent assay] reader). Inhibition of the reaction was calculated using [(A0A1)/A0] × 100, where A0 is the absorbance without the sample and A1 is the absorbance with the sample. The IC50 value was determined from a plot of percentage inhibition versus sample concentration. Acarbose was used as the standard control, and the experiment was performed in triplicate.

2.2.3 MTT assay

The cytotoxicity of parent compound (1) and modified compounds (1a–1j) was measured by using the MTT assay method following the protocol of Suwito et al [22]. The cancer cells were seeded in a 96-well plate at a density of 1 × 104 cells/well with a phenol red-free RPMI (Roswell Park Memorial Institute) 1640 medium (containing 10% FBS) and kept for 24 h. Subsequently, the tested compound (various concentrations) was applied for 24 h. After addition of 0.5% MTT solution, the incubation was continued for a further 4 h at 37°C/5% CO2. The stop solution (0.04 N HCl in isopropanol) was added to the culture medium in each well. The spectroscopic measurements were carried out at 570 nm (peak) and 630 nm (bottom) using an ELISA reader. The experiment was conducted in triplicate. Doxorubicin was used as a positive control.

  1. Ethical approval: The conducted research is not related to either human or animal use.

3 Results and discussion

3.1 Semi-synthesis

In this study, derivatization of nordentatin (1) was carried out by using various benzoyl chlorides (Figure 1). The reaction was simple, quick, and has resulted in ten new pyranocoumarin benzoates (1a1j) (Figure 2). Their structures were not only elucidated based on spectroscopic data but also compared with the structure of nordentatin (1) (Figures S1–S46). The FT-IR spectral data supported the presence of the –OH stretching group broad band in compound 1, and the absence of –OH stretching in compounds 1a–1j. In addition, the 13C-NMR spectral data revealed the presence of one more carbonyl carbon from the benzoyl group at δc ∼ 161 ppm. The presence of fluoro-containing compounds was inferred from splitting patterns and coupling constants in 13C-NMR.

Figure 2 Structures of derivatives 1a–1j from nordentatin (1).
Figure 2

Structures of derivatives 1a–1j from nordentatin (1).

3.1.1 Spectral data of compound 1a, 2,2-dimethyl-10-(2-methylbut-3-en-2-yl)-8-oxo-2H,8H-pyrano[3,2-g]chromen-5-yl 4-bromobenzoate

Nordentatin (108.2 mg, 0.3467 mmol), 4-bromobenzoyl chloride (121.6 mg, 0.5500 mmol), yield 43.2%. UV (MeOH), λmax (log ε) 349 (0.79), 257 (2.87), 231 (1.0). M.p. 203–206°C. FT-IR 3,080, 2,972, 2,929, 2,873, 1,747, 1,730, 1,641, 1,618, 1,552 cm−1. 1H NMR (chloroform-d, 600 MHz) δ 2 × 8.11 (1H, d, J = 8.7 Hz), 2 × 7.72 (1H, d, J = 8.7 Hz), 7.53 (1H, d, J = 9.7 Hz), 6.33 (1H, dd, J = 17.4, 10.6 Hz), 6.26 (1H, d, J = 10.0 Hz), 6.19 (1H, d, J = 9.7 Hz), 5.69 (1H, d, J = 10.0 Hz), 4.98 (1H, dd, J = 17.4, 1.0 Hz), 4.92 (1H, dd, J = 10.6, 1.0 Hz), 2 × 1.70 (3H, s), 2 × 1.47 (3H, s). 13C NMR (151 MHz, chloroform-d), δ 163.7, 160.1, 155.6, 2 × 153.8, 149.5, 141.2, 137.8, 132.4, 131.8, 131.8, 129.9, 126.8, 121.3, 115.6, 112.8, 112.0, 108.5, 2 × 107.2, 77.9, 41.4, 2 × 29.4, 2 × 27.7. DART-MS, C26H24BrO5 [M + H]+, m/z: 495.0805 (calcd mass for C26H24BrO5, m/z: 495.0807), C26H2481BrO5 [M + H]+, m/z: 497.0784.

3.1.2 Spectral data of compound 1b, 2,2-dimethyl-10-(2-methylbut-3-en-2-yl)-8-oxo-2H,8H-pyrano[3,2-g]chromen-5-yl 3-chlorobenzoate

Nordentatin (107.4 mg, 0.3442 mmol), 3-chlorobenzoyl chloride (90.3 mg, 0.5163 mmol), yield 74.9%, λmax (log ε) 340 (0.772), 268 (1.703), 233 (1.952), 233 (1.952). M.p. 173–174°C. FT-IR 3,080, 2,964, 2,922, 2,852, 1,743, 1,724, 1,620, 1,602, 1,554 cm−1. 1H NMR (chloroform-d, 600 MHz) δ 8.33 (1H, dd, J = 6.9, 2.1 Hz), 8.16 (1H, ddd, J = 8.5, 4.5, 2.2 Hz), 2 × 7.52 (1H, d, J = 9.7 Hz), 7.34 (1H, t, J = 8.5 Hz), 6.33 (1H, dd, J = 17.4, 10.6 Hz), 6.24 (1H, d, J = 10.0 Hz), 6.20 (1H, d, J = 9.7 Hz), 5.71 (1H, d, J = 10.0 Hz), 4.98 (1H, d, J = 17.4 Hz), 4.92 (1H, m), 1.70 (6H, s), 1.48 (6H, s). 13C NMR data (see the supplementary material). DART-MS, C26H24ClO5, m/z: 451.1313 [M + H]+ (calcd mass for C26H24ClO5, m/z: 451.1312), C26H2437ClO5 [M + H]+, m/z: 453.1286.

3.1.3 Spectral data of compound 1c, 2,2-dimethyl-10-(2-methylbut-3-en-2-yl)-8-oxo-2H,8H-pyrano[3,2-g]chromen-5-yl 2-chloro-4-nitrobenzoate

Nordentatin (115.6 mg, 0.3686 mmol), 2-chloro,4-nitrobenzoyl chloride (121.6 mg, 0.5500 mmol), yield 43.6%. UV (MeOH), λmax (log ε) 340 (0.509), 267 (1.468). M.p. 197–198°C. FT-IR 3,105, 3,088, 2,995, 2,968, 2,933, 1,762, 1,720, 1,618, 1,535 cm−1. 1H NMR (chloroform-d, 600 MHz) δ 8.45 (1H, m), 8.29 (2H, d, J = 1.0 Hz), 7.60 (1H, d, J = 9.7 Hz), 6.32 (2H, m), 6.24 (1H, d, J = 9.7 Hz), 5.76 (1H, d J = 9.7 Hz), 4.98 (1H, dd, J = 17.4, 0.9 Hz), 4.92 (1H, dd, J = 10.6, 0.9 Hz), 1.70 (6H, s), 1.49 (6H, s). 13C NMR data (see the supplementary material). DART-MS, C26H23ClNO7, m/z: 496.1162 [M + H]+ (calcd mass for C26H23ClNO7, m/z: 496.1163), C26H2337ClNO7 [M + H]+, m/z: 498.1129.

3.1.4 Spectral data of compound 1d, 2,2-dimethyl-10-(2-methylbut-3-en-2-yl)-8-oxo-2H,8H-pyrano[3,2-g]chromen-5-yl 3-chloro-4-fluorobenzoate

Nordentatin (108.2 mg, 0.3467 mmol), 3-chloro-4-fluoro-benzoyl chloride (100.3 mg, 0.5201 mmol), yield 54.5%. UV (MeOH), λmax (log ε) 340 (0.772), 268 (1.703), 233 (1.952), 233 (1.952). M.p. 173–174°C. FT-IR 3,086, 3,049, 2,970, 2,935, 2,922, 1,747, 1,720, 1,618, 1,598, 1,548 cm−1. 1H NMR (chloroform-d, 600 MHz) δ 8.33 (1H, dd, J = 6.9, 2.1 Hz), 8.16 (1H, ddd, J = 8.5, 4.5, 2.2 Hz), 7.52 (1H, d, J = 9.7 Hz), 7.34 (1H, t, J = 8.5 Hz), 6.33 (1H, dd, J = 17.4, 10.6 Hz), 6.24 (1H, d, J = 10.0 Hz), 6.20 (1H, d, J = 9.7 Hz), 5.71 (1H, d, J = 10.0 Hz), 4.98 (1H, d, J = 17.4 Hz), 4.94–4.90 (1H, m), 1.70 (6H, s), 1.48 (6H, s). 13C NMR data (see the supplementary material). DART-MS, C26H23ClFO5, m/z: 469.1221 [M + H]+ (calcd mass for C26H23ClFO5,m/z: 469.1218), C26H2337ClFO5 [M + H]+, m/z: 471.1191.

3.1.5 Spectral data of compound 1e, 2,2-dimethyl-10-(2-methylbut-3-en-2-yl)-8-oxo-2H,8H-pyrano[3,2-g]chromen-5-yl 3-bromobenzoate

Nordentatin (104.8 mg, 0.3358 mmol), 3-bromo-benzoyl chloride (110.5 mg, 0.5037 mmol), yield 93.5%. UV (MeOH), λmax (log ε) 340 (0.782), 268 (1.811), 209 (4.0). M.p. 127–128°C. FT-IR, 3,080, 2,964, 2,935, 2,883, 1,741, 1,724, 1,620, 1,602, 1,554 cm−1. 1H NMR (chloroform-d, 600 MHz) δ 8.32 (1H, dd, J = 1.7 Hz), 8.12 (1H, dt, J = 7.8, 1.3 Hz), 7.90 (1H, ddd, J = 8.0, 2.0, 1.0 Hz), 7.54 (1H, d, J = 9.7 Hz), 7.41 (1H, dt, J = 7.9 Hz), 6.33 (1H, dd, J = 17.4, 10.6 Hz), 6.26 (1H, d, J = 10.0 Hz), 6.21 (1H, d, J = 9.7 Hz), 5.70 (1H, d, J = 10.0 Hz), 4.98 (1H, dd, J = 17.4, 1.0 Hz), 4.92 (1H, dd, J = 10.6, 1.0 Hz), 1.70 (6H, s), 1.48 (6H, s). 13C NMR data (see the supplementary material). DART-MS, C26H24BrO5, m/z: 495.0802 [M + H]+ (calcd mass for C26H24BrO5, m/z: 495.0807), C26H2481BrO5 [M + H]+, m/z: 497.0779.

3.1.6 Spectral data of compound 1f, 2,2-dimethyl-10-(2-methylbut-3-en-2-yl)-8-oxo-2H,8H-pyrano[3,2-g]chromen-5-yl 4-butylbenzoate

Nordentatin (113.6 mg, 0.3467 mmol), 4-butylbenzoyl chloride (107.4 mg, 0.5461 mmol), yield 37%. UV (MeOH), λmax (log ε) 349 (0.79), 257 (2.87), 231 (1.0). M.p. 77–78°C. 1H NMR (chloroform-d, 600 MHz), δ 2 × 8.16 (1H, d, J = 8.3 Hz), 7.57 (1H, d, J = 9.7 Hz), 2 × 7.37 (1H, d, J = 8.3 Hz), 6.34 (1H, dd, J = 17.4, 10.6 Hz), 6.17 (1H, d, J = 9.7 Hz), 5.67 (1H, d, J = 10.0 Hz), 4.98 (1H, dd, J = 17.4, 1.0 Hz), 4.91 (1H, dd, J = 10.6, 1.0 Hz), 2.79–2.67 (2H, m), 1.70 (6H, s), 1.67 (4H, tt, J = 8.9, 7.6 Hz), 1.47 (6H, s), 1.40 (2H, dq, J = 14.7, 7.4 Hz), 0.96 (3H, t, J = 7.4 Hz). 13C NMR data (see the supplementary material). DART-MS, C30H33O5, m/z 473.2328 [M + H]+ (calcd mass for C30H33O5, m/z: 473.2328).

3.1.7 Spectral data of compound 1g, 2,2-dimethyl-10-(2-methylbut-3-en-2-yl)-8-oxo-2H,8H-pyrano[3,2-g]chromen-5-yl 2,4,6-trichlorobenzoate

Nordentatin (107.6 mg, 0.3448 mmol), 2,4,6-trichlorobenzoyl chloride (126.1 mg, 0.5172 mmol) yield 90%. UV (MeOH), λmax (log ε, MeOH), 349 (0.396), 267 (0.949), 259 (0.868). M.p. 149–150°C. FT-IR 3,093, 3,078, 2,999, 2,980, 2,929, 1,762, 1,728, 1,614, 1,600, 1,579, 1,550 cm−1. 1H NMR (chloroform-d, 600 MHz), δ 7.93 (1H, d, J = 9.7 Hz), 7.50 (2H, s), 6.65 (1H, d, J = 10.0 Hz), 6.32 (1H, dd, J = 17.4, 10.6 Hz), 6.24 (1H, d, J = 9.7 Hz), 5.77 (1H, d, J = 10.0 Hz), 4.97 (1H, dd, J = 17.4, 0.9 Hz), 4.91 (1H, dd, J = 10.6, 1.0 Hz), 1.70 (6H, s), 1.49 (6H, s). 13C NMR data (see the supplementary material). DART-MS, C26H22Cl3O5, m/z: 519.0536 [M + H]+ (calcd mass for C26H22Cl3O5, m/z: 519.0533), C26H2237ClCl2O5 [M + H]+, m/z: 521.0505, C26H2237Cl2ClO5 [M + H]+, m/z: 523.0471, C26H2237Cl3O5 [M + H]+, m/z: 525.0438.

3.1.8 Spectral data of compound 1h, 2,2-dimethyl-10-(2-methylbut-3-en-2-yl)-8-oxo-2H,8H-pyrano[3,2-g]chromen-5-yl 3-(trifluoromethyl)benzoate

Nordentatin (110.7 mg, 0.3548 mmol), 3-(trifluoromethyl)benzoyl chloride (110.9 mg, 0.5322 mmol), yield 65.4%. UV (MeOH), λmax (log ε) 352 (1.078), 272 (3.769), 228 (4.0), 209 (2.085). M.p. 77–78°C. FT-IR 3,095, 3,080, 2,966, 2,937, 2,924, 2,883, 1,747, 1,728, 1,620, 1,602, 1,552 cm−1. 1H NMR (chloroform-d, 600 MHz) δ 8.51 (1H, s), 8.45 (1H, d, J = 7.8 Hz), 7.98 (1H, d, J = 7.9 Hz), 7.74 (1H, t, J = 7.8 Hz), 7.54 (1H, d, J = 9.7 Hz), 6.34 (1H, dd, J = 17.4, 10.6 Hz), 6.26 (1H, d, J = 10.0 Hz), 6.20 (1H, d, J = 9.7 Hz), 5.71 (1H, d, J = 10.0 Hz), 5.02–4.96 (1H, m), 4.95–4.89 (1H, m), 1.71 (6H, s), 1.48 (6H, s). 13C NMR data (see the supplementary material). DART-MS, C27H24F3 O5, m/z: 485.1571 [M + H]+ (calcd mass for C27H24F3O5, m/z: 485.1576).

3.1.9 Spectral data of compound 1i, 2,2-dimethyl-10-(2-methylbut-3-en-2-yl)-8-oxo-2H,8H-pyrano[3,2-g]chromen-5-yl 3,5-bis(trifluoromethyl)benzoate

Nordentatin (103.6 mg, 0.33205 mmol), 3,5-bis(trifluoromethyl)benzoyl chloride (121.6 mg, 0.5500 mmol), yield 41%. UV (MeOH), λmax (log ε) 349 (0.79), 257 (2.87), 231 (1.0). M.p. 186–187°C. FT-IR 3,089, 3,066, 2,999, 2,981, 2,937, 1,759, 1,737, 1,620, 1,604, 1,552 cm−1. 1H NMR (chloroform-d, 600 MHz) δ 8.69 (2H, s), 8.22 (1H, s), 7.51 (1H, d, J = 9.7 Hz), 6.33 (1H, dd, J = 17.4, 10.6 Hz), 6.23 (1H, d, J = 10.0 Hz), 6.21 (1H, d, J = 9.7 Hz), 5.73 (1H, d, J = 10.0 Hz), 4.99 (1H, dd, J = 17.4, 0.8 Hz), 4.93 (1H, dd, J = 10.6, 0.9 Hz), 1.71 (6H, s), 1.49 (6H, s). 13C NMR data (see the supplementary material). DART-MS C28H23F6O5, m/z: 553.1440 [M + H]+ (calcd mass for C28H23F6O5, m/z: 553.1450).

3.1.10 Spectral data of compound 1j, 2,2-dimethyl-10-(2-methylbut-3-en-2-yl)-8-oxo-2H,8H-pyrano[3,2-g]chromen-5-yl 4-iodobenzoate

Nordentatin (103.0 mg, 0.3301 mmol), 4-iodobenzoyl chloride (131.8 mg, 0.4952 mmol), yield 58%. UV (MeOH), λmax (log ε) 349 (0.79), 257 (2.87), 231 (1.0). M.p. 156–157°C. FT-IR 3,072, 2,972, 2,927, 2,870, 1,747, 1,730, 1,643, 1,614, 1,587 cm−1. 1H NMR (chloroform-d, 600 MHz) δ 7.95 (4H, s), 7.52 (1H, d, J = 9.7 Hz), 6.33 (1H, dd, J = 17.4, 10.6 Hz), 6.25 (1H, d, J = 10.0 Hz), 6.19 (1H, d, J = 9.7 Hz), 5.69 (1H, d, J = 10.0 Hz), 4.98 (1H, dd, J = 17.4, 0.9 Hz), 4.91 (1H, dd, J = 10.6, 1.0 Hz), 1.70 (6H, s), 1.47 (6H, s). 13C NMR data (see the supplementary material). DART-MS, C26H24IO5, m/z: 543.0667 [M + H]+ (calcd mass for C26H24IO5, m/z: 543.0668).

3.2 α-Glucosidase inhibition activity of nordentatin (1) and its derivatives (1a–1j)

All the compounds were evaluated for their inhibitory effect on yeast α-glucosidase (Table 1). Among the modified compounds, 1b, 1d, 1e, 1f, 1h, 1i, and 1j exhibited a high inhibition of α-glucosidase with IC50 values of 1.54, 9.05, 4.87, 20.25, 12.34, 5.67, and 2.43 mM (acarbose 7.57 mM) (Table 1) [23]. The highest inhibition activity was shown when chloride was at the meta-position as in 1b, followed by para-substituted iodide (1j) and the meta-position of bromide (1e). They are also comparable with the standard control acarbose. In addition, compounds containing bistrifluoromethane (1i), trifluoromethane (1h), 3-chloro, 5-fluoro (1d), and para-butyl groups (1f) showed higher activity than nordentatin (1) with an IC50 value of 36.7 mM. Based on this study, we can conclude that the activity of some compounds increased after modification, while that of some compounds decreased, e.g., 1a, 1c, and 1g showed no inhibition.

Table 1

Results of α-glucosidase inhibition assay of derivatives 1a–1j

Compound no.IC50 (mM)
Yeast α-glucosidase
1aNI*
1b1.54
1cNI*
1d9.05
1e4.87
1f20.25
1gNI*
1h12.34
1i5.67
1j2.43
136.7
Acarbose (std)7.57

NI* = no inhibition at concentration ≤ 5 mg/mL

3.3 Cytotoxic activity of nordentatin (1) and modified compounds (1a–1j) against HeLa and T47D cell lines

The cytotoxicity of all modified compounds was tested against a HeLa cell line, and their IC50 values were compared with those of nordentatin (1) and the standard control doxorubicin (Table 2). All tested compounds showed low activity with IC50 values ranging from 0.25 to 1.25 mM against HeLa cells.

Table 2

Investigation of the cytotoxicity of the modified compounds (1a–1j) against HeLa and T47D cell lines

Compound nameIC50 (mM)
HeLaT47D
1a0.450.10
1b0.390.04
1c0.400.24
1d0.280.11
1e0.590.12
1f1.251.57
1g0.520.41
1h0.340.38
1i0.250.24
1j0.350.23
10.610.04
Doxorubicin0. 4 × 10−20.6 × 10−4

However, the results indicated that the modified compounds that contain fluorobenzoyl groups (1i, 1d, 1h, and 1b) have more cytotoxic activity than others and nordentatin (1). On the other hand, the activity of compounds 1j, 1c, 1a, 1g, 1e, and 1f was lower (Table 2). The investigation of cell proliferation of modified compounds was also performed on a T47D cell line (Table 2). The results revealed that the modified compounds have moderate to low inhibition against the cancer cell line with the IC50 values ranging from 0.043 to 1.57 mM, but their activity was lower than the activity of the parent compound, nordentatin (1) with an IC50 value of 0.041 mM (Table 2). The structure–activity relationship study showed that the modified compounds with chloro and bromo compounds at meta and para positions had stronger inhibition than others.

4 Conclusions

In the current work, we continue our previous research concerning bioactive secondary metabolites from natural medicinal plants and their derivatives. As a result, ten new pyranocoumarin benzoate derivatives were semi-synthesized in good to excellent yields from natural nordentatin (1) by an acylation method. Both parent and modified compounds were tested for their antidiabetic activity by an α-glucosidase assay and anticancer activity (HeLa and T47D cell lines) by an MTT assay. Among the tested compounds, modified compound 1b showed the highest inhibition activity against yeast α-glucosidase enzymes, in particular 5 times higher than that of acarbose and 20 times higher than that of the parent compound, nordentatin (1). Among the tested compounds, modified compound 1i showed the highest cytotoxic activity against the HeLa cell line. Compound 1b showed a moderate cytotoxic activity against T47D but it was less effective than the parent compound, nordentatin (1). As a result of this study, we can conclude that some modified compounds are promising, since their activity is comparable with that of standard drugs. Especially, active compound 1b, 2,2-dimethyl-10-(2-methylbut-3-en-2-yl)-8-oxo2H,8H-pyrano[3,2-g]chromen-5-yl-3-chlorobenzoate, should be studied as a potential alternative α-glucosidase inhibitor.


tel: +62-31-593-6501, fax: +62-31-593-6502

Acknowledgements

The authors would like to thank (1) Universitas Airlangga for Airlangga Development Scholarship (ADS), (2) Riset Mandat Grand of Universitas Airlangga that has funded this research, (3) Faculty of Pharmacy, Meijo University, Nagoya, Japan, for measuring NMR and HRMS data, and (4) Dr. Kaido Simon and Prof. M. Iqbal Chaudhary for editing this manuscript.

  1. Conflict of interest: The authors declare no conflict of interest.

References

[1] Kongkathip N, Kongkathip B. Constituents and bioactivities of Clausena excavata. Heterocycles. 2009;79(C):121–44.10.3987/REV-08-SR(D)2Suche in Google Scholar

[2] Thant TM, Aminah NS, Kristanti AN, Ramadhan R, Phuwapraisirisan P, Takaya Y. A new pyrano coumarin from Clausena excavata roots displaying dual inhibition against α-glucosidase and free radical. Nat Prod Res. 2019;1–6.10.1080/14786419.2019.1586696Suche in Google Scholar PubMed

[3] Takemura Y, Nakamura K, Hirusawa T, Ju-ichi M, Ito C, Furukawa H. Four new furanone-coumarins from Clausena excavata. Chem Pharm Bull (Tokyo). 2000;48(4):582–4.10.1248/cpb.48.582Suche in Google Scholar PubMed

[4] Taufiq-Yap YH, et al. A new cytotoxic carbazole alkaloid from Clausena excavata. Nat Prod Res. 2007;21(9):310–3.10.1080/14786410701258875Suche in Google Scholar PubMed

[5] Kumar R, Saha A, Saha D. A new antifungal coumarin from Clausena excavata. Fitoterapia. 2012;83(1):230–3.10.1016/j.fitote.2011.11.003Suche in Google Scholar PubMed

[6] Lipeeva AV, et al. Design, synthesis and antibacterial activity of coumarin-1,2,3-triazole hybrids obtained from natural furocoumarin peucedanin. 2019;24:1–23.10.3390/molecules24112126Suche in Google Scholar PubMed PubMed Central

[7] Davorka Z, Muratovic S, Makuc D, Plavec J, Cetina M, Nagl A, et al. Benzylidene-bis-(4-hydroxycoumarin) and benzopyrano-coumarin derivatives: synthesis, 1H/13C-NMR conformational and X-ray crystal structure studies and in vitro antiviral activity evaluations. Molecules. 2011;16(7):6023–40.10.3390/molecules16076023Suche in Google Scholar PubMed PubMed Central

[8] Noipha K, Thongthoom T, Songsiang U, Boonyarat C, Yenjai C. Carbazoles and coumarins from Clausena harmandiana stimulate glucose uptake in L6 myotubes. Diabetes Res Clin Pract. 2010;90(3):67–71.10.1016/j.diabres.2010.09.005Suche in Google Scholar PubMed

[9] Flores-Bocanegra L, González-Andrade M, Bye R, Linares E, Mata R. α-Glucosidase inhibitors from Salvia circinata. J Nat Prod. 2017;80(5):1584–93.10.1021/acs.jnatprod.7b00155Suche in Google Scholar PubMed

[10] Gothai S, Ganesan P, Park SY, Fakurazi S, Choi DK, Arulselvan P. Natural phyto-bioactive compounds for the treatment of type 2 diabetes: Inflammation as a target. Nutrients. 2016;8(8):461–38.10.3390/nu8080461Suche in Google Scholar PubMed PubMed Central

[11] Bathula C, Mamidala R, Thulluri C, Agarwal R, Jha KK, Munshi P, et al. Substituted furopyridinediones as novel inhibitors of α-glucosidase. RSC Adv. 2015;5:90374–85.10.1039/C5RA19255BSuche in Google Scholar

[12] Du ZY, et al. α-Glucosidase inhibition of natural curcuminoids and curcumin analogs. Eur J Med Chem. 2006;41(2):213–8.10.1016/j.ejmech.2005.10.012Suche in Google Scholar PubMed

[13] Taha M, et al. Synthesis of novel triazinoindole-based thiourea hybrid: a study on α-glucosidase inhibitors and their molecular docking. Molecules. 2019;24:1–16.10.3390/molecules24213819Suche in Google Scholar PubMed PubMed Central

[14] Zhao X, et al. Resveratroloside alleviates postprandial hyperglycemia in diabetic mice by competitively inhibiting α-glucosidase. J Agric Food Chem. 2019;67(10):2886–93.10.1021/acs.jafc.9b00455Suche in Google Scholar PubMed

[15] Santana FR, et al. Evaluation of the cytotoxicity on breast cancer cell of extracts and compounds isolated from Hyptis pectinata (L.) poit. Nat Prod Res. 2020;34(1):102–9.10.1080/14786419.2019.1628747Suche in Google Scholar PubMed

[16] Potikanond S, et al. Kaempferia parviflora extract exhibits anti-cancer activity against HeLa cervical cancer cells. Front Pharmacol. 2017;8(Sep):1–12.10.3389/fphar.2017.00630Suche in Google Scholar PubMed PubMed Central

[17] Chattopadhyay S, Bisaria VS, Panda AK, Srivastava AK. Cytotoxicity of in vitro produced podophyllotoxin from Podophyllum hexandrum on human cancer cell line. Nat Prod Res. 2004;18(1):51–7.10.1080/1057563031000122095Suche in Google Scholar PubMed

[18] Novakovic M, Simic S, Koracak L, Zlatovic M, Ilic-Tomic T, Asakawa Y, et al. Chemo- and biocatalytic esterification of marchantin A and cytotoxic activity of ester derivatives. Fitoterapia. 2020;142:104520.10.1016/j.fitote.2020.104520Suche in Google Scholar PubMed

[19] Wu CZ, et al. Synthesis and evaluation of bakuchiol derivatives as potential anticancer agents. Molecules. 2018;23(3):1–12.10.3390/molecules23030515Suche in Google Scholar PubMed PubMed Central

[20] Pena MJ, Botubol-Ares JM, nJames Hanson R, Galan RH, Collado IG. Efficient o-acylation of alcohols and ohenol using Cp2TiCl as a reaction promoter. Eur J Org Chem. 2016;2016(21):3584–91.10.1002/ejoc.201600496Suche in Google Scholar PubMed PubMed Central

[21] Ramadhan R, Worawalai W, Phuwapraisirisan P. New onoceranoid xyloside from Lansium parasiticum. Nat Prod Res. 2019;33(20):2917–24.10.1080/14786419.2018.1510395Suche in Google Scholar PubMed

[22] Suwito H, Hardiyanti HD, Ul Haq K, Kristanti AN, Khasanah M. (E)-3-[3-(4-Morpholinophenyl)acryloyl]-2H-chromen-2-one. Molbank. 2018;2018(4):1–5.10.3390/M1027Suche in Google Scholar

[23] Choi CW, et al. Yeast α-glucosidase inhibition by isoflavones from plants of leguminosae as an in vitro alternative to acarbose. J Agric Food Chem. 2010;58(18):9988–93.10.1021/jf101926jSuche in Google Scholar PubMed

Received: 2020-02-15
Revised: 2020-05-20
Accepted: 2020-06-06
Published Online: 2020-08-03

© 2020 Tin Myo Thant et al., published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Artikel in diesem Heft

  1. Regular Articles
  2. Electrochemical antioxidant screening and evaluation based on guanine and chitosan immobilized MoS2 nanosheet modified glassy carbon electrode (guanine/CS/MoS2/GCE)
  3. Kinetic models of the extraction of vanillic acid from pumpkin seeds
  4. On the maximum ABC index of bipartite graphs without pendent vertices
  5. Estimation of the total antioxidant potential in the meat samples using thin-layer chromatography
  6. Molecular dynamics simulation of sI methane hydrate under compression and tension
  7. Spatial distribution and potential ecological risk assessment of some trace elements in sediments and grey mangrove (Avicennia marina) along the Arabian Gulf coast, Saudi Arabia
  8. Amino-functionalized graphene oxide for Cr(VI), Cu(II), Pb(II) and Cd(II) removal from industrial wastewater
  9. Chemical composition and in vitro activity of Origanum vulgare L., Satureja hortensis L., Thymus serpyllum L. and Thymus vulgaris L. essential oils towards oral isolates of Candida albicans and Candida glabrata
  10. Effect of excess Fluoride consumption on Urine-Serum Fluorides, Dental state and Thyroid Hormones among children in “Talab Sarai” Punjab Pakistan
  11. Design, Synthesis and Characterization of Novel Isoxazole Tagged Indole Hybrid Compounds
  12. Comparison of kinetic and enzymatic properties of intracellular phosphoserine aminotransferases from alkaliphilic and neutralophilic bacteria
  13. Green Organic Solvent-Free Oxidation of Alkylarenes with tert-Butyl Hydroperoxide Catalyzed by Water-Soluble Copper Complex
  14. Ducrosia ismaelis Asch. essential oil: chemical composition profile and anticancer, antimicrobial and antioxidant potential assessment
  15. DFT calculations as an efficient tool for prediction of Raman and infra-red spectra and activities of newly synthesized cathinones
  16. Influence of Chemical Osmosis on Solute Transport and Fluid Velocity in Clay Soils
  17. A New fatty acid and some triterpenoids from propolis of Nkambe (North-West Region, Cameroon) and evaluation of the antiradical scavenging activity of their extracts
  18. Antiplasmodial Activity of Stigmastane Steroids from Dryobalanops oblongifolia Stem Bark
  19. Rapid identification of direct-acting pancreatic protectants from Cyclocarya paliurus leaves tea by the method of serum pharmacochemistry combined with target cell extraction
  20. Immobilization of Pseudomonas aeruginosa static biomass on eggshell powder for on-line preconcentration and determination of Cr (VI)
  21. Assessment of methyl 2-({[(4,6-dimethoxypyrimidin-2-yl)carbamoyl] sulfamoyl}methyl)benzoate through biotic and abiotic degradation modes
  22. Stability of natural polyphenol fisetin in eye drops Stability of fisetin in eye drops
  23. Production of a bioflocculant by using activated sludge and its application in Pb(II) removal from aqueous solution
  24. Molecular Properties of Carbon Crystal Cubic Structures
  25. Synthesis and characterization of calcium carbonate whisker from yellow phosphorus slag
  26. Study on the interaction between catechin and cholesterol by the density functional theory
  27. Analysis of some pharmaceuticals in the presence of their synthetic impurities by applying hybrid micelle liquid chromatography
  28. Two mixed-ligand coordination polymers based on 2,5-thiophenedicarboxylic acid and flexible N-donor ligands: the protective effect on periodontitis via reducing the release of IL-1β and TNF-α
  29. Incorporation of silver stearate nanoparticles in methacrylate polymeric monoliths for hemeprotein isolation
  30. Development of ultrasound-assisted dispersive solid-phase microextraction based on mesoporous carbon coated with silica@iron oxide nanocomposite for preconcentration of Te and Tl in natural water systems
  31. N,N′-Bis[2-hydroxynaphthylidene]/[2-methoxybenzylidene]amino]oxamides and their divalent manganese complexes: Isolation, spectral characterization, morphology, antibacterial and cytotoxicity against leukemia cells
  32. Determination of the content of selected trace elements in Polish commercial fruit juices and health risk assessment
  33. Diorganotin(iv) benzyldithiocarbamate complexes: synthesis, characterization, and thermal and cytotoxicity study
  34. Keratin 17 is induced in prurigo nodularis lesions
  35. Anticancer, antioxidant, and acute toxicity studies of a Saudi polyherbal formulation, PHF5
  36. LaCoO3 perovskite-type catalysts in syngas conversion
  37. Comparative studies of two vegetal extracts from Stokesia laevis and Geranium pratense: polyphenol profile, cytotoxic effect and antiproliferative activity
  38. Fragmentation pattern of certain isatin–indole antiproliferative conjugates with application to identify their in vitro metabolic profiles in rat liver microsomes by liquid chromatography tandem mass spectrometry
  39. Investigation of polyphenol profile, antioxidant activity and hepatoprotective potential of Aconogonon alpinum (All.) Schur roots
  40. Lead discovery of a guanidinyl tryptophan derivative on amyloid cascade inhibition
  41. Physicochemical evaluation of the fruit pulp of Opuntia spp growing in the Mediterranean area under hard climate conditions
  42. Electronic structural properties of amino/hydroxyl functionalized imidazolium-based bromide ionic liquids
  43. New Schiff bases of 2-(quinolin-8-yloxy)acetohydrazide and their Cu(ii), and Zn(ii) metal complexes: their in vitro antimicrobial potentials and in silico physicochemical and pharmacokinetics properties
  44. Treatment of adhesions after Achilles tendon injury using focused ultrasound with targeted bFGF plasmid-loaded cationic microbubbles
  45. Synthesis of orotic acid derivatives and their effects on stem cell proliferation
  46. Chirality of β2-agonists. An overview of pharmacological activity, stereoselective analysis, and synthesis
  47. Fe3O4@urea/HITh-SO3H as an efficient and reusable catalyst for the solvent-free synthesis of 7-aryl-8H-benzo[h]indeno[1,2-b]quinoline-8-one and indeno[2′,1′:5,6]pyrido[2,3-d]pyrimidine derivatives
  48. Adsorption kinetic characteristics of molybdenum in yellow-brown soil in response to pH and phosphate
  49. Enhancement of thermal properties of bio-based microcapsules intended for textile applications
  50. Exploring the effect of khat (Catha edulis) chewing on the pharmacokinetics of the antiplatelet drug clopidogrel in rats using the newly developed LC-MS/MS technique
  51. A green strategy for obtaining anthraquinones from Rheum tanguticum by subcritical water
  52. Cadmium (Cd) chloride affects the nutrient uptake and Cd-resistant bacterium reduces the adsorption of Cd in muskmelon plants
  53. Removal of H2S by vermicompost biofilter and analysis on bacterial community
  54. Structural cytotoxicity relationship of 2-phenoxy(thiomethyl)pyridotriazolopyrimidines: Quantum chemical calculations and statistical analysis
  55. A self-breaking supramolecular plugging system as lost circulation material in oilfield
  56. Synthesis, characterization, and pharmacological evaluation of thiourea derivatives
  57. Application of drug–metal ion interaction principle in conductometric determination of imatinib, sorafenib, gefitinib and bosutinib
  58. Synthesis and characterization of a novel chitosan-grafted-polyorthoethylaniline biocomposite and utilization for dye removal from water
  59. Optimisation of urine sample preparation for shotgun proteomics
  60. DFT investigations on arylsulphonyl pyrazole derivatives as potential ligands of selected kinases
  61. Treatment of Parkinson’s disease using focused ultrasound with GDNF retrovirus-loaded microbubbles to open the blood–brain barrier
  62. New derivatives of a natural nordentatin
  63. Fluorescence biomarkers of malignant melanoma detectable in urine
  64. Study of the remediation effects of passivation materials on Pb-contaminated soil
  65. Saliva proteomic analysis reveals possible biomarkers of renal cell carcinoma
  66. Withania frutescens: Chemical characterization, analgesic, anti-inflammatory, and healing activities
  67. Design, synthesis and pharmacological profile of (−)-verbenone hydrazones
  68. Synthesis of magnesium carbonate hydrate from natural talc
  69. Stability-indicating HPLC-DAD assay for simultaneous quantification of hydrocortisone 21 acetate, dexamethasone, and fluocinolone acetonide in cosmetics
  70. A novel lactose biosensor based on electrochemically synthesized 3,4-ethylenedioxythiophene/thiophene (EDOT/Th) copolymer
  71. Citrullus colocynthis (L.) Schrad: Chemical characterization, scavenging and cytotoxic activities
  72. Development and validation of a high performance liquid chromatography/diode array detection method for estrogen determination: Application to residual analysis in meat products
  73. PCSK9 concentrations in different stages of subclinical atherosclerosis and their relationship with inflammation
  74. Development of trace analysis for alkyl methanesulfonates in the delgocitinib drug substance using GC-FID and liquid–liquid extraction with ionic liquid
  75. Electrochemical evaluation of the antioxidant capacity of natural compounds on glassy carbon electrode modified with guanine-, polythionine-, and nitrogen-doped graphene
  76. A Dy(iii)–organic framework as a fluorescent probe for highly selective detection of picric acid and treatment activity on human lung cancer cells
  77. A Zn(ii)–organic cage with semirigid ligand for solvent-free cyanosilylation and inhibitory effect on ovarian cancer cell migration and invasion ability via regulating mi-RNA16 expression
  78. Polyphenol content and antioxidant activities of Prunus padus L. and Prunus serotina L. leaves: Electrochemical and spectrophotometric approach and their antimicrobial properties
  79. The combined use of GC, PDSC and FT-IR techniques to characterize fat extracted from commercial complete dry pet food for adult cats
  80. MALDI-TOF MS profiling in the discovery and identification of salivary proteomic patterns of temporomandibular joint disorders
  81. Concentrations of dioxins, furans and dioxin-like PCBs in natural animal feed additives
  82. Structure and some physicochemical and functional properties of water treated under ammonia with low-temperature low-pressure glow plasma of low frequency
  83. Mesoscale nanoparticles encapsulated with emodin for targeting antifibrosis in animal models
  84. Amine-functionalized magnetic activated carbon as an adsorbent for preconcentration and determination of acidic drugs in environmental water samples using HPLC-DAD
  85. Antioxidant activity as a response to cadmium pollution in three durum wheat genotypes differing in salt-tolerance
  86. A promising naphthoquinone [8-hydroxy-2-(2-thienylcarbonyl)naphtho[2,3-b]thiophene-4,9-dione] exerts anti-colorectal cancer activity through ferroptosis and inhibition of MAPK signaling pathway based on RNA sequencing
  87. Synthesis and efficacy of herbicidal ionic liquids with chlorsulfuron as the anion
  88. Effect of isovalent substitution on the crystal structure and properties of two-slab indates BaLa2−xSmxIn2O7
  89. Synthesis, spectral and thermo-kinetics explorations of Schiff-base derived metal complexes
  90. An improved reduction method for phase stability testing in the single-phase region
  91. Comparative analysis of chemical composition of some commercially important fishes with an emphasis on various Malaysian diets
  92. Development of a solventless stir bar sorptive extraction/thermal desorption large volume injection capillary gas chromatographic-mass spectrometric method for ultra-trace determination of pyrethroids pesticides in river and tap water samples
  93. A turbidity sensor development based on NL-PI observers: Experimental application to the control of a Sinaloa’s River Spirulina maxima cultivation
  94. Deep desulfurization of sintering flue gas in iron and steel works based on low-temperature oxidation
  95. Investigations of metallic elements and phenolics in Chinese medicinal plants
  96. Influence of site-classification approach on geochemical background values
  97. Effects of ageing on the surface characteristics and Cu(ii) adsorption behaviour of rice husk biochar in soil
  98. Adsorption and sugarcane-bagasse-derived activated carbon-based mitigation of 1-[2-(2-chloroethoxy)phenyl]sulfonyl-3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl) urea-contaminated soils
  99. Antimicrobial and antifungal activities of bifunctional cooper(ii) complexes with non-steroidal anti-inflammatory drugs, flufenamic, mefenamic and tolfenamic acids and 1,10-phenanthroline
  100. Application of selenium and silicon to alleviate short-term drought stress in French marigold (Tagetes patula L.) as a model plant species
  101. Screening and analysis of xanthine oxidase inhibitors in jute leaves and their protective effects against hydrogen peroxide-induced oxidative stress in cells
  102. Synthesis and physicochemical studies of a series of mixed-ligand transition metal complexes and their molecular docking investigations against Coronavirus main protease
  103. A study of in vitro metabolism and cytotoxicity of mephedrone and methoxetamine in human and pig liver models using GC/MS and LC/MS analyses
  104. A new phenyl alkyl ester and a new combretin triterpene derivative from Combretum fragrans F. Hoffm (Combretaceae) and antiproliferative activity
  105. Erratum
  106. Erratum to: A one-step incubation ELISA kit for rapid determination of dibutyl phthalate in water, beverage and liquor
  107. Review Articles
  108. Sinoporphyrin sodium, a novel sensitizer for photodynamic and sonodynamic therapy
  109. Natural products isolated from Casimiroa
  110. Plant description, phytochemical constituents and bioactivities of Syzygium genus: A review
  111. Evaluation of elastomeric heat shielding materials as insulators for solid propellant rocket motors: A short review
  112. Special Issue on Applied Biochemistry and Biotechnology 2019
  113. An overview of Monascus fermentation processes for monacolin K production
  114. Study on online soft sensor method of total sugar content in chlorotetracycline fermentation tank
  115. Studies on the Anti-Gouty Arthritis and Anti-hyperuricemia Properties of Astilbin in Animal Models
  116. Effects of organic fertilizer on water use, photosynthetic characteristics, and fruit quality of pear jujube in northern Shaanxi
  117. Characteristics of the root exudate release system of typical plants in plateau lakeside wetland under phosphorus stress conditions
  118. Characterization of soil water by the means of hydrogen and oxygen isotope ratio at dry-wet season under different soil layers in the dry-hot valley of Jinsha River
  119. Composition and diurnal variation of floral scent emission in Rosa rugosa Thunb. and Tulipa gesneriana L.
  120. Preparation of a novel ginkgolide B niosomal composite drug
  121. The degradation, biodegradability and toxicity evaluation of sulfamethazine antibiotics by gamma radiation
  122. Special issue on Monitoring, Risk Assessment and Sustainable Management for the Exposure to Environmental Toxins
  123. Insight into the cadmium and zinc binding potential of humic acids derived from composts by EEM spectra combined with PARAFAC analysis
  124. Source apportionment of soil contamination based on multivariate receptor and robust geostatistics in a typical rural–urban area, Wuhan city, middle China
  125. Special Issue on 13th JCC 2018
  126. The Role of H2C2O4 and Na2CO3 as Precipitating Agents on The Physichochemical Properties and Photocatalytic Activity of Bismuth Oxide
  127. Preparation of magnetite-silica–cetyltrimethylammonium for phenol removal based on adsolubilization
  128. Topical Issue on Agriculture
  129. Size-dependent growth kinetics of struvite crystals in wastewater with calcium ions
  130. The effect of silica-calcite sedimentary rock contained in the chicken broiler diet on the overall quality of chicken muscles
  131. Physicochemical properties of selected herbicidal products containing nicosulfuron as an active ingredient
  132. Lycopene in tomatoes and tomato products
  133. Fluorescence in the assessment of the share of a key component in the mixing of feed
  134. Sulfur application alleviates chromium stress in maize and wheat
  135. Effectiveness of removal of sulphur compounds from the air after 3 years of biofiltration with a mixture of compost soil, peat, coconut fibre and oak bark
  136. Special Issue on the 4th Green Chemistry 2018
  137. Study and fire test of banana fibre reinforced composites with flame retardance properties
  138. Special Issue on the International conference CosCI 2018
  139. Disintegration, In vitro Dissolution, and Drug Release Kinetics Profiles of k-Carrageenan-based Nutraceutical Hard-shell Capsules Containing Salicylamide
  140. Synthesis of amorphous aluminosilicate from impure Indonesian kaolin
  141. Special Issue on the International Conf on Science, Applied Science, Teaching and Education 2019
  142. Functionalization of Congo red dye as a light harvester on solar cell
  143. The effect of nitrite food preservatives added to se’i meat on the expression of wild-type p53 protein
  144. Biocompatibility and osteoconductivity of scaffold porous composite collagen–hydroxyapatite based coral for bone regeneration
  145. Special Issue on the Joint Science Congress of Materials and Polymers (ISCMP 2019)
  146. Effect of natural boron mineral use on the essential oil ratio and components of Musk Sage (Salvia sclarea L.)
  147. A theoretical and experimental study of the adsorptive removal of hexavalent chromium ions using graphene oxide as an adsorbent
  148. A study on the bacterial adhesion of Streptococcus mutans in various dental ceramics: In vitro study
  149. Corrosion study of copper in aqueous sulfuric acid solution in the presence of (2E,5E)-2,5-dibenzylidenecyclopentanone and (2E,5E)-bis[(4-dimethylamino)benzylidene]cyclopentanone: Experimental and theoretical study
  150. Special Issue on Chemistry Today for Tomorrow 2019
  151. Diabetes mellitus type 2: Exploratory data analysis based on clinical reading
  152. Multivariate analysis for the classification of copper–lead and copper–zinc glasses
  153. Special Issue on Advances in Chemistry and Polymers
  154. The spatial and temporal distribution of cationic and anionic radicals in early embryo implantation
  155. Special Issue on 3rd IC3PE 2020
  156. Magnetic iron oxide/clay nanocomposites for adsorption and catalytic oxidation in water treatment applications
  157. Special Issue on IC3PE 2018/2019 Conference
  158. Exergy analysis of conventional and hydrothermal liquefaction–esterification processes of microalgae for biodiesel production
  159. Advancing biodiesel production from microalgae Spirulina sp. by a simultaneous extraction–transesterification process using palm oil as a co-solvent of methanol
  160. Topical Issue on Applications of Mathematics in Chemistry
  161. Omega and the related counting polynomials of some chemical structures
  162. M-polynomial and topological indices of zigzag edge coronoid fused by starphene
Heruntergeladen am 12.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/chem-2020-0149/html
Button zum nach oben scrollen